Physician profile
Supriyo U Ghosh
NPI 1366430019
$653.13
in general payments reported to CMS, 2019-2025
12 companies · $60.93 in 2025
The $60.93 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $22.30 · 2021: $99.00 · 2022: $155 · 2023: $74.88 · 2024: $81.91 · 2025: $60.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $184.00 | 2021-2022 | |
| Novo Nordisk INC | $119.55 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $74.19 | 2019 | |
| Lilly USA, LLC | $51.94 | 2019-2023 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $51.04 | 2022-2025 | |
| Glaxosmithkline, LLC. | $32.35 | 2019-2023 | Arexvy, Shingrix |
| Pfizer INC. | $31.60 | 2022-2023 | |
| Exact Sciences Corporation | $26.40 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $25.78 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Abbvie INC. | $20.68 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $18.60 | 2024 | Airsupra |
| Medtronic Vascular, INC. | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriyo Ghosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.